Excise exemption for etoposide added, altering tariff treatment and exempting the anti-cancer drug from central excise. The Central Government amended an existing excise notification to insert Serial No. 32 in the Annexure, adding etoposide and thereby extending exemption treatment to the anti cancer drug under the referenced tariff notification, exercised under statutory powers in the public interest.